Peripheral Macrophage-derived Exosomes Promote Repair After Spinal Cord Injury by Inducing Local Anti-inflammatory Type Microglial Polarization Via Increasing Autophagy
Overview
Affiliations
Treatment for spinal cord injury (SCI) remains a challenge worldwide, and inflammation is a major cause of secondary injury after SCI. Peripheral macrophages (PMs) have been verified as a key factor that exert anti-inflammatory effects after SCI, but the mechanism is unidentified. As local macrophages, microglia also exert significant effects after SCI, especially polarization. Exosomes show source cell-like biological functions to target cells and have been the subject of much research in recent years. Thus, we hypothesized the PM-derived exosomes (PM-Exos) play an important role in signal transmission with local microglia and can be used therapeutic agents for SCI in a series of and studies. For the experiment, three groups of Sprague-Dawley (SD) rats subjected to spinal cord contusion injury were injected with 200 µg/ml PM-Exos, 20 µg/ml PM-Exos or PBS via the tail vein. Recovery of the rats and of spinal cord function were observed. , we investigated the potential anti-inflammatory mechanism of PM-Exos and evaluated microglial autophagy, anti-inflammatory type microglia polarization and the upstream signaling pathway. The results showed that spinal cord function and recovery were better in the PM-Exo groups than the control group. In the study, microglial autophagy levels and the expression of anti-inflammatory type microglia were higher in the experimental groups than the control group. Moreover, the expression of proteins related to the PI3K/AKT/mTOR autophagic signaling pathway was suppressed in the PM-Exo groups. PM-Exos have a beneficial effect in SCI, and activation of microglial autophagy via inhibition of the PI3K/AKT/mTOR signaling pathway, enhancing the polarization of anti-inflammatory type microglia, that may play a major role in the anti-inflammatory process.
Macrophage-derived extracellular vesicles as new players in chronic non-communicable diseases.
Lin F, Luo H, Wang J, Li Q, Zha L Front Immunol. 2025; 15:1479330.
PMID: 39896803 PMC: 11782043. DOI: 10.3389/fimmu.2024.1479330.
Stem Cell-Derived Extracellular Vesicle-Mediated Therapeutic Signaling in Spinal Cord Injury.
Poongodi R, Hsu Y, Yang T, Huang Y, Yang K, Lin H Int J Mol Sci. 2025; 26(2).
PMID: 39859437 PMC: 11765593. DOI: 10.3390/ijms26020723.
Tools for regulating metabolic diseases: extracellular vesicles from adipose macrophages.
Zhang L, Lou K, Zhang Y, Leng Y, Huang Y, Liao X Front Endocrinol (Lausanne). 2024; 15:1510712.
PMID: 39735643 PMC: 11674605. DOI: 10.3389/fendo.2024.1510712.
Regulation of dynamic spatiotemporal inflammation by nanomaterials in spinal cord injury.
Liu Z, Xiang C, Zhao X, Aizawa T, Niu R, Zhao J J Nanobiotechnology. 2024; 22(1):767.
PMID: 39696584 PMC: 11657436. DOI: 10.1186/s12951-024-03037-8.
Huang K, Fang J, Sun W, Zeng Y, Shi B, Ren B Sci Rep. 2024; 14(1):30099.
PMID: 39627300 PMC: 11615303. DOI: 10.1038/s41598-024-81332-y.